| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 107983 | Toxicologie Analytique et Clinique | 2015 | 8 Pages |
Abstract
recent epidemiological data suggest that the global prevalence is still low. The patterns of use vary widely. The main motivations for their consumption are the legal status, their easy access and low coast as well as the promise of a “high” similar to or stronger than cannabis. Paradoxically, these “positive” effects seem less intense and/or shorter than those observed with the cannabis, while psychiatric and neurological complications occur much more frequently. The abuse liability of synthetic cannabinoids seems less important than cannabis. These results have to be confirmed by large epidemiological and clinical studies.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Forensic Medicine
Authors
Anne-Laure Pélissier-Alicot,